• LanzaTech and Twelve, two carbon transformation startups, have partnered to develop polypropylene from carbon emissions. Polypropylene is a key material essential for medical supplies including syringes and IV bags and in many other products used in day-to-day lives, such as textiles, furniture, and automotives.

• The partnership will utilize two proprietary technologies—Twelve’s O12 technology and LanzaTech’s Pollution to Products technology.

• Currently, 100 percent of polypropylene used worldwide is made from petrochemicals. The partnership paves the way to produce polypropylene using carbon dioxide and water instead of using fossil fuels. This is estimated to reduce nearly 700 million tons of carbon dioxide emissions per year.

• Twelve and LanzaTech have been awarded a grant of USD 200,000 from Impact Squared, a social impact consultancy firm, to proceed with the partnership.

<ul><li> Analyst QuickTake: LanzaTech is a pioneer in carbon dioxide to chemicals transformation having developed its technology for well over a decade and carries over 1,000 patents to date. Twelve, on the other hand, is relatively young, having launched in 2015 but recently made headlines with its USD 57 million Series A funding round in July . Having access to LanzaTech’s technology and expertise will likely accelerate Twelve’s development progress. Twelve is currently taking pre-orders for its carbon transformation solution with proceeds from the recent funding round expected to be used to scale its technology.</ul>